The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 232.80
Bid: 233.10
Ask: 233.20
Change: -15.80 (-6.36%)
Spread: 0.10 (0.043%)
Open: 235.00
High: 238.00
Low: 231.40
Prev. Close: 248.60
LGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

19 Nov 2019 08:36

RNS Number : 8785T
Legal & General Group Plc
19 November 2019
 

Legal & General: Business Update

 

Legal & General Group Plc ("Legal & General" or "the Group") announces that it expects to launch shortly a GBP-denominated benchmark Tier 2 subordinated debt issuance, taking advantage of current favourable market conditions. The Group will confirm the amount of debt raised after the issuance has settled.

 

Legal & General also highlights that:

 

·; LGRI (our Institutional Retirement business) has transacted £8.5 billion of global Pension Risk Transfer (PRT) to 31 October 2019. This includes a further £1.2 billion of UK PRT and a further $0.6 billion of US PRT (£0.5 billion) written since Half Year 2019. The financial metrics and Solvency II capital strain of these deals are in line with previous transactions. Additionally, LGRI is in exclusive negotiations on a further global PRT pipeline of £3 billion which we expect to complete before the year end.

 

·; LGRR (our Retail Retirement business) has achieved individual annuity sales of £829 million to 31 October 2019, up 34% year on year. Lifetime mortgage advances were £823 million to 31 October 2019, down 15% year on year.

 

·; LGIM (our Investment Management business) has achieved external net flows of £83 billion in the year to 31 October, which includes a further £23 billion of external net flows since Half Year 2019. LGIM's AUM as at 31 October is £1.2 trillion, an increase of circa £200 billion since Full Year 2018.

 

The Group estimates its year-end Solvency ratio will be in a range of 171% to 176% (H1 2019: 171%). This estimate does not include the benchmark debt issuance announced today, but does include capital we expect to deploy on new business before year-end. It assumes unchanged market conditions to 31 December 2019.

 

Nigel Wilson, Chief Executive, Legal & General, said:

"Our business continues to go from strength to strength. Our year-to-date operating performance across all five of our divisions is good reflecting the strong execution of our stated strategy. We remain disciplined in our deployment of capital, and our balance sheet and net cash flow are strong. We are taking advantage of favourable market conditions to raise debt, and remain confident in Legal & General's ability to grow sustainable profits over the long-term."

 

Notes to editors

Legal & General Group Plc

Established in 1836, Legal & General is one of the UK's leading financial services groups and a major global investor, with international businesses in the US, Europe, Middle East and Asia. With over £1.2 trillion in total assets under management, we are the UK's largest investment manager for corporate pension schemes and a UK market leader in pension risk transfer, life insurance, workplace pensions and retirement income. As at 18 November 2019, Legal & General has a market capitalisation of £16.7 billion.

 

Debt Profile

For further information, see: https://www.legalandgeneralgroup.com/investors/debt-investors/

 

Forward-looking statements

This announcement may contain certain forward-looking statements relating to Legal & General, its plans and its current goals and expectations relating to future financial condition, performance and results. By their nature, forward-looking statements involve uncertainty because they relate to future events and circumstances which are beyond Legal & General's control, including, among others, UK domestic and global economic and business conditions, market-related risks such as fluctuations in interest rates and exchange rates, the policies and actions of regulatory and Governmental authorities, the impact of competition, the timing impact of these events and other uncertainties of future acquisitions or combinations within relevant industries. As a result, Legal & General's actual future condition, performance and results may differ materially from the plans, goals and expectations set out in these forward-looking statements and persons reading this announcement should not place reliance on forward-looking statements. These forward-looking statements are made only as at the date on which such statements are made and Legal & General does not undertake to update forward-looking statements contained in this announcement or any other forward-looking statement it may make.

 

 

Further information

Investors

Edward Houghton Head of Investor Relations +44 (0)20 3124 2091

Alyssa Manning Investor Relations Director +44 (0)20 3124 2047

Sujee Rajah Investor Relations Director +1 312 964 3034

 

 

Media

John Godfrey Corporate Affairs Director +44 (0)20 3124 2090

Graeme Wilson Tulchan Communications +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDVKLBFKFFXFBL
Date   Source Headline
18th Apr 20245:00 pmRNSDirector/PDMR Shareholding
17th Apr 20245:00 pmRNSDirector/PDMR Shareholding
11th Apr 20243:00 pmRNSPublication of a Prospectus
11th Apr 202410:00 amRNSNotice of AGM
9th Apr 20245:07 pmRNSDirector/PDMR Shareholding
3rd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSTotal Voting Rights
21st Mar 20249:00 amRNSDirector/PDMR Shareholding
13th Mar 202410:30 amRNSAnnual Financial Report
6th Mar 20247:00 amRNSL&G Full Year Results 2023 Part 2
6th Mar 20247:00 amRNSL&G Full Year Results 2023 Part 1
4th Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSTotal Voting Rights
27th Feb 20249:00 amRNSChange of Group Remuneration Committee Chair
23rd Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20245:00 pmRNSDirector Declaration
2nd Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20245:00 pmRNSTotal Voting Rights
5th Jan 20245:00 pmRNSBlock listing Interim Review
3rd Jan 20245:00 pmRNSDirector/PDMR Shareholding
4th Dec 20235:00 pmRNSDirector/PDMR Shareholding
1st Dec 20235:00 pmRNSDirector/PDMR Shareholding
1st Dec 20235:00 pmRNSDirector/PDMR Shareholding
1st Dec 20235:00 pmRNSTotal Voting Rights
24th Nov 20237:00 amRNSL&G agrees full buy-in for Boots Pension Scheme
9th Nov 20239:00 amRNSDirector Declaration
2nd Nov 20235:00 pmRNSDirector/PDMR Shareholding
1st Nov 20235:00 pmRNSDirector/PDMR Shareholding
1st Nov 20235:00 pmRNSDirector/PDMR Shareholding
1st Nov 20235:00 pmRNSTotal Voting Rights
3rd Oct 20235:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20235:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20235:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20235:00 pmRNSTotal Voting Rights
28th Sep 20235:00 pmRNSDirector/PDMR Shareholding
28th Sep 20235:00 pmRNSDirector Declaration
28th Sep 20235:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20239:00 amRNSChange of Senior Independent Director
4th Sep 20235:00 pmRNSDirector/PDMR Shareholding
1st Sep 20235:00 pmRNSDirector/PDMR Shareholding
1st Sep 20235:00 pmRNSDirector/PDMR Shareholding
1st Sep 20235:00 pmRNSTotal Voting Rights
15th Aug 20237:00 amRNSL&G Half Year Results 2023 Part 2

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.